NCT04114344

Brief Summary

Open prospective randomised clinical trial enrolling women who suffer from inguinal or femoral hernia, to evaluate if TEP approach is superior to TAPP concerning postoperative development, principally postoperative pain, with no increase of recurrent hernia at the one-year follow-up visit.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 12, 2019

Completed
21 days until next milestone

First Posted

Study publicly available on registry

October 3, 2019

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2023

Completed
Last Updated

July 27, 2022

Status Verified

July 1, 2022

Enrollment Period

3.4 years

First QC Date

September 12, 2019

Last Update Submit

July 26, 2022

Conditions

Keywords

WomanInguinal HerniaTAPPTEPOutpatient SurgeryAmbulatory Surgery

Outcome Measures

Primary Outcomes (3)

  • Post operative pain

    Post operative pain, measured with Visual Analogue Scale (VAS) (from 0 to 10 points) World Health Organization (WHO)

    24 hours

  • Recurrence

    Recurrence of inguinal hernia in the one-year follow-up

    One year

  • Complications

    Postoperative complications including wound complications (seroma, haematoma, infection), gastrointestinal complications (ileus, fistula), urological complications (acute retention, haematuria) and hernia complications (recurrence, chronic groin pain) will be reported. Occurrence of major complications will be registered, including intestinal injury, major vascular lesion, bleeding over 500cc and peritonitis.

    One year

Secondary Outcomes (2)

  • Operating time

    180 minutes

  • Hospital stay

    24 hours

Study Arms (2)

TAPP (Trans Abdominal PrePeritoneal)

ACTIVE COMPARATOR

Trans Abdominal PrePeritoneal approach to inguinal hernia repair

Procedure: TAPP

TEP (Totally Extra Peritoneal)

EXPERIMENTAL

Totally Extra Peritoneal approach to inguinal hernia repair

Procedure: TEP

Interventions

TAPPPROCEDURE

Trans Abdominal Pre Peritoneal approach

TAPP (Trans Abdominal PrePeritoneal)
TEPPROCEDURE

Total Extra Peritoneal approach

TEP (Totally Extra Peritoneal)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Inguinofemoral hernia, EHS (European Hernia Society) classification.
  • Patient over 18 years old.
  • Signed informed consent form.
  • Female
  • Meeting of outpatient discharge criteria, determined by Aldrete´s test

You may not qualify if:

  • Loss of domain.
  • Abdominal skin grafts.
  • Previous preperitoneal (open or laparoscopic) prosthetic mesh.
  • Incarcerated hernia.
  • Previous complications such as infection, fistulae…
  • Not candidate for ambulatory surgery
  • Pregnancy or desire for pregnancy in the first postoperative year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Virgen del Rocío University Hospital

Seville, 41013, Spain

Location

MeSH Terms

Conditions

Hernia, Inguinal

Interventions

tetra-4-amidinophenoxypropanetetraethylpyrazine

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 12, 2019

First Posted

October 3, 2019

Study Start

May 1, 2019

Primary Completion

October 1, 2022

Study Completion

May 1, 2023

Last Updated

July 27, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations